Satori Capital launches ‘Satori Neuro’ mental health strategy | national business


Satori Capital, a multi-strategy investment firm founded on the principles of mindful capitalism, today announced the launch of a new business focused on transformational companies developing innovative mental health solutions.

This press release features multimedia. View the full version here:

Dr. Amy Cross (Photo: Business Wire)

Satori Neuro targets companies developing cutting-edge therapies and disruptive business models to address the world’s most critical mental health challenges. Supporting this kind of innovation aligns directly with Satori’s goal: to create, fund, and inspire businesses that uplift humanity.

“We have spent a significant amount of time and resources over the past several years evaluating opportunities related to mental health,” said James Hadaway, chief investment officer and managing partner of Satori Alpha. “Since we strongly believe in the huge potential of these innovative solutions, we decided that if we could find the perfect Chief Investment Officer to lead a focused strategy, we would explore it ourselves.”

In searching for this ideal leader, Satori managers have focused on the key qualities they believe are essential to success in this evolving sector. This Chief Investment Officer will need not only an outstanding scientific and operational background, but also deep relationships with entrepreneurs and business leaders, as well as the ability to act as a trusted and value-adding partner for strategy portfolio companies. Satori also sought an emphatic leader who was strongly aligned with Satori’s purpose and core values.

An extensive search led to a leader just like that: Dr. Amy Cruz. Dr. Cross brings more than 20 years of experience in science, technology and innovation, with a particular focus on neurotechnology and human performance. She is a former General Partner at Prime Movers Lab, a venture capital firm that invests in science-driven early-stage startups developing solutions to some of the world’s most pressing problems. She was previously Chief Scientific Officer at applied neuroscience research firm Optios, and has prior experience as CTO of Cubic Global Defense and as Program Director at the Defense Advanced Research Projects Agency (DARPA). Dr. Cross holds a Bachelor of Science in Cell and Structural Biology and a Ph.D. in neuroscience from the University of Illinois at Urbana-Champaign.

“Amy’s expertise and subject matter expertise, combined with her impressive professional background, positions her ideally to lead this innovative neuroscience and mental health strategy,” said Randy Eisenman, Co-Founder and Managing Partner of Satori. “Together with the operational experience of our directors in building and managing successful companies, we believe that Amy’s expertise, experience and unique relationships give us a distinct advantage in identifying promising and innovative businesses in this sector.”

Satori’s assessment of Dr. Cruz’s superiority in her field has resonated with entrepreneurs and business leaders she has worked with in her previous roles, including Dr. Jonathan Sporn, CEO of Gilgamesh Pharmaceuticals, a clinical-stage biotech company developing new medicines that harness therapy. The drug promises to revolutionize the treatment of mental illness.

“Amy is the perfect collaborator, both as an investor and as a thought partner,” said Sporn. You have played a major role in the success of our company, Gilgamesh Pharmaceuticals. Amy is one of the most dynamic people I’ve worked with in my career, and she brings this energy to her work investing in projects through every interaction. It’s scientifically astute, practical and remarkably connected – any company would be lucky to share it.”

Under Dr. Cross’s direction, Satori Neuro will seek opportunities to address the greatest mental health, brain health, and wellness challenges and opportunities. The innovative therapies involved include a wide range of treatment modalities, from anesthetic medicine and transcranial magnetic stimulation to virtual/augmented reality protocols and non-invasive brainwave devices, all designed to provide solutions to challenges such as treatment-resistant depression, post-traumatic stress disorders, addiction, substance abuse, neurological disorders and more. .

“This is an exciting time for neuroscience and brain health,” said Dr. Cruz. “We have learned more about the human brain in the past five years than we have previously learned in the past 50 – and this knowledge is rapidly translating into real-world applications that hold the promise of transforming our entire approach to mental health challenges we have grappled with throughout human history. I believe these innovations are the future. human flourishing, and I’m thrilled to be partnering with a purpose-driven company like Satori in supporting companies developing cutting-edge therapies and new business models.”

About Satori Capital

Satori Capital is a Texas-based multi-strategy investment firm founded on the principles of conscious capitalism. The purpose of the company is to create, fund, and inspire businesses that uplift humanity. Satori business partners in private equity through majority and minority investments with leadership teams of EBITDA $5-$50 million companies that operate with a long-term perspective, adhere to their mission or purpose, and create value for all stakeholders . Satori Alpha’s alternative investment platform, Satori Alpha, creates and manages customized portfolios designed to meet the unique goals of sophisticated private, family office, and institutional investors. Through the Satori XL Partnership Program, Satori partners with managers it believes are highly skilled in generating sustainable alpha and will leverage Satori’s experience, relationships, and resources, all in support of building a thriving and lasting business. Satori Environmental invests in securities affected by the global energy sector’s shift towards more renewable sources. For additional information, please visit

View source version at

Contact: Elaine Henderson

(214) 390-6270

Keyword: texas united states north america

Industry keyword: professional services mental health neurological health finance public health

Source: Satori Capital

Copyright 2023 Business Wire.

Posted: 01/02/2023 01:23 PM / Disc: 01/02/2023 01:22 PM

Leave a Comment